Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,272
Total Claims
$2.1M
Drug Cost
682
Beneficiaries
$3,029
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-78%
Opioid rate vs peers
0.5% vs 2.2% avg
+115%
Cost per patient vs peers
$3,029 vs $1,411 avg
+25%
Brand preference vs peers
13.3% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.5%
Opioid Rate
50
Opioid Claims
$241
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,352 claims · $1.8M
Generic: 8,805 claims · $287K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 137 | $285K |
| Dulaglutide | 130 | $275K |
| Empagliflozin | 118 | $207K |
| Apixaban | 96 | $151K |
| Dapagliflozin Propanediol | 84 | $129K |
| Tirzepatide | 27 | $71K |
| Sitagliptin Phosphate | 34 | $41K |
| Rivaroxaban | 31 | $38K |
| Mirabegron | 27 | $36K |
| Sacubitril/Valsartan | 21 | $35K |
| Insulin Degludec | 13 | $31K |
| Insulin Glargine,hum.Rec.Anlog | 27 | $26K |
| Fluticasone/Umeclidin/Vilanter | 16 | $26K |
| Budesonide/Formoterol Fumarate | 37 | $24K |
| Atorvastatin Calcium | 1,084 | $20K |
Prescribing Profile
Patient Profile
75
Avg Age
52%
Female
1.05
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About